27
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The HDAC6/8/10 inhibitor TH34 induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          High histone deacetylase (HDAC) 8 and HDAC10 expression levels have been identified as predictors of exceptionally poor outcomes in neuroblastoma, the most common extracranial solid tumor in childhood. HDAC8 inhibition synergizes with retinoic acid treatment to induce neuroblast maturation in vitro and to inhibit neuroblastoma xenograft growth in vivo. HDAC10 inhibition increases intracellular accumulation of chemotherapeutics through interference with lysosomal homeostasis, ultimately leading to cell death in cultured neuroblastoma cells. So far, no HDAC inhibitor covering HDAC8 and HDAC10 at micromolar concentrations without inhibiting HDACs 1, 2 and 3 has been described. Here, we introduce TH34 (3-( N-benzylamino)-4-methylbenzhydroxamic acid), a novel HDAC6/8/10 inhibitor for neuroblastoma therapy. TH34 is well-tolerated by non-transformed human skin fibroblasts at concentrations up to 25 µM and modestly impairs colony growth in medulloblastoma cell lines, but specifically induces caspase-dependent programmed cell death in a concentration-dependent manner in several human neuroblastoma cell lines. In addition to the induction of DNA double-strand breaks, HDAC6/8/10 inhibition also leads to mitotic aberrations and cell-cycle arrest. Neuroblastoma cells display elevated levels of neuronal differentiation markers, mirrored by formation of neurite-like outgrowths under maintained TH34 treatment. Eventually, after long-term treatment, all neuroblastoma cells undergo cell death. The combination of TH34 with plasma-achievable concentrations of retinoic acid, a drug applied in neuroblastoma therapy, synergistically inhibits colony growth (combination index (CI) < 0.1 for 10 µM of each). In summary, our study supports using selective HDAC inhibitors as targeted antineoplastic agents and underlines the therapeutic potential of selective HDAC6/8/10 inhibition in high-grade neuroblastoma.

          Electronic supplementary material

          The online version of this article (10.1007/s00204-018-2234-8) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references60

          • Record: found
          • Abstract: found
          • Article: not found

          The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men.

          Protein lysine deacetylases have a pivotal role in numerous biological processes and can be divided into the Rpd3/Hda1 and sirtuin families, each having members in diverse organisms including prokaryotes. In vertebrates, the Rpd3/Hda1 family contains 11 members, traditionally referred to as histone deacetylases (HDAC) 1-11, which are further grouped into classes I, II and IV. Whereas most class I HDACs are subunits of multiprotein nuclear complexes that are crucial for transcriptional repression and epigenetic landscaping, class II members regulate cytoplasmic processes or function as signal transducers that shuttle between the cytoplasm and the nucleus. Little is known about class IV HDAC11, although its evolutionary conservation implies a fundamental role in various organisms.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            HDAC family: What are the cancer relevant targets?

            Histone deacetylases comprise a family of 18 genes, which are grouped into classes I-IV based on their homology to their respective yeast orthologues. Classes I, II, and IV consist of 11 family members, which are referred to as "classical" HDACs, whereas the 7 class III members are called sirtuins. Classical HDACs are a promising novel class of anti-cancer drug targets. First HDAC inhibitors have been evaluated in clinical trials and show activity against several cancer diseases. However, these compounds act unselectively against several or all 11 HDAC family members. As a consequence, clinical phase I trials document a wide range of side effects. Therefore, the current challenge in the field is to define the cancer relevant HDAC family member(s) in a given tumor type and to design selective inhibitors, which target cancer cells but leave out normal cells. Knockout of single HDAC family members in mice produces a variety of phenotypes ranging from early embryonic death to viable animals with only discrete alterations, indicating that potential side effects of HDAC inhibitors depend on the selectivity of the compounds. Recently, several studies have shown that certain HDAC family members are aberrantly expressed in several tumors and have non-redundant function in controlling hallmarks of cancer cells. The aim of this review is to discuss individual HDAC family members as drug targets in cancer taking into consideration their function under physiological conditions and their oncogenic potential in malignant disease.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              SMC complexes: from DNA to chromosomes.

              SMC (structural maintenance of chromosomes) complexes - which include condensin, cohesin and the SMC5-SMC6 complex - are major components of chromosomes in all living organisms, from bacteria to humans. These ring-shaped protein machines, which are powered by ATP hydrolysis, topologically encircle DNA. With their ability to hold more than one strand of DNA together, SMC complexes control a plethora of chromosomal activities. Notable among these are chromosome condensation and sister chromatid cohesion. Moreover, SMC complexes have an important role in DNA repair. Recent mechanistic insight into the function and regulation of these universal chromosomal machines enables us to propose molecular models of chromosome structure, dynamics and function, illuminating one of the fundamental entities in biology.
                Bookmark

                Author and article information

                Contributors
                +49-6221-423388 , i.oehme@kitz-heidelberg.de
                Journal
                Arch Toxicol
                Arch. Toxicol
                Archives of Toxicology
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                0340-5761
                1432-0738
                9 June 2018
                9 June 2018
                2018
                : 92
                : 8
                : 2649-2664
                Affiliations
                [1 ]GRID grid.461742.2, Preclinical Program, , Hopp Children’s Cancer Center at NCT Heidelberg (KiTZ), ; 69120 Heidelberg, Germany
                [2 ]ISNI 0000 0004 0492 0584, GRID grid.7497.d, Clinical Cooperation Unit Pediatric Oncology, , German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), ; Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
                [3 ]ISNI 0000 0001 2190 4373, GRID grid.7700.0, Faculty of Biosciences, , Heidelberg University, ; Im Neuenheimer Feld 234, 69120 Heidelberg, Germany
                [4 ]ISNI 0000 0001 0679 2801, GRID grid.9018.0, Department of Medicinal Chemistry, Institute of Pharmacy, , Martin-Luther-University Halle-Wittenberg, ; W.-Langenbeck-Str. 4, 06120 Halle, Germany
                [5 ]GRID grid.5963.9, Institute of Pharmaceutical Sciences, , Albert-Ludwigs-Universität Freiburg, ; Albertstraße 25, 79104 Freiburg, Germany
                [6 ]ISNI 0000 0004 0492 0584, GRID grid.7497.d, Cancer Drug Development Group, , German Cancer Research Center (DKFZ), ; Im Neuenheimer Feld 580, 69120 Heidelberg, Germany
                [7 ]ISNI 0000 0004 0492 0584, GRID grid.7497.d, Research Group Neuroblastoma Genomics, , German Cancer Research Center (DKFZ), ; Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
                [8 ]ISNI 0000 0001 0328 4908, GRID grid.5253.1, Department of Pediatric Oncology, Hematology and Immunology, , University Hospital Heidelberg, ; Im Neuenheimer Feld 430, 69120 Heidelberg, Germany
                Author information
                http://orcid.org/0000-0002-0827-2356
                Article
                2234
                10.1007/s00204-018-2234-8
                6063332
                29947893
                88e210f9-4edb-4163-9dd1-38106cebdcda
                © The Author(s) 2018

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

                History
                : 22 February 2018
                : 4 June 2018
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100001659, Deutsche Forschungsgemeinschaft;
                Award ID: Si868/13-1
                Award ID: Ju295/13-1
                Award ID: W1461/4-1
                Award ID: Oe542/2-1
                Award Recipient :
                Funded by: Hector foundation
                Award ID: M71
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100005973, Dr. Mildred Scheel Stiftung für Krebsforschung;
                Award ID: 112065
                Award Recipient :
                Categories
                Genotoxicity and Carcinogenicity
                Custom metadata
                © Springer-Verlag GmbH Germany, part of Springer Nature 2018

                Toxicology
                selective histone deacetylase inhibitor,hdac8,hdac10,dna repair,differentiation,targeted therapy

                Comments

                Comment on this article